Faculty profile

Richard Harrigan

ResearcherUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Richard Harrigan

Researcher

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2026.
Principal investigator on 4 research grants (4 CIHR), most recently in 2012.
Supervised 4 trainees who won CIHR awards, most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hiv Pharmacogenetics Therapy Resistance Antiretroviral Therapy Drug Resistance Genotyping Next Generation Sequencing

Latest papers

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.
The lancet. HIV · 2026
Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore.
bioRxiv : the preprint server for biology · 2020
HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade.
PloS one · 2020

All 20 publications

Latest funding

Household transmission of SARS-CoV-2 in a well-characterized African cohort
CIHR · 2020 · Co-investigator
Rapid Response to Emerging Serious Pathogen Outbreaks using Next-gen Data: R2ESPOND
CIHR · 2020 · Co-investigator
$1,000,000
Sex as a Biological Variable Supplement - Rapid Response to Emerging Serious Pathogen Outbreaks using Next-gen Data: R2ESPOND
CIHR · 2020 · Co-investigator
$25,000

All 23 grants and awards

20 publications.

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

Clemente T, Stam AJ, Elvstam O, Geretti AM, Harrigan R, Parczewski M, Mackie NE, Spagnuolo V, Hofstra M, Venter F, Kuritzkes DR, Llibre JM, Shafer RW, Schapiro J, Martinez E, Kityo-Mutuluuza C, Nijhuis M, Björkman P, Charpentier C, Collins S, Günthard HF, Cecchini D, Castagna A, Brusselaers N, Wensing AM, International Consensus Group on the Clinical Management of Low-Level Viremia

The lancet. HIV2026

DOI: 10.1016/s2352-3018(26)00107-4 PMID: 42276093

Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore.

Tyson JR, James P, Stoddart D, Sparks N, Wickenhagen A, Hall G, Choi JH, Lapointe H, Kamelian K, Smith AD, Prystajecky N, Goodfellow I, Wilson SJ, Harrigan R, Snutch TP, Loman NJ, Quick J

bioRxiv : the preprint server for biology2020

DOI: 10.1101/2020.09.04.283077 PMID: 32908977

HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade.

Cholette F, Joy J, Pelcat Y, Thompson LH, Pilon R, Ho J, Capina R, Archibald C, Blanchard JF, Emmanuel F, Reza T, Dar N, Harrigan R, Kim J, Sandstrom P

PloS one2020

DOI: 10.1371/journal.pone.0237560 PMID: 32857765

Treatment Experience and Repeat Pregnancy Impact the Effectiveness of Non-Nucleoside Reverse Transcription Inhibitor-Highly Active Antiretroviral Therapy for the Prevention of Mother to Child Transmission of Human Immunodeficiency Virus.

Martin IB, Read S, Harrigan R, Gomez MP

AIDS research and human retroviruses2020

DOI: 10.1089/aid.2019.0001 PMID: 32408754

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance.

Douglas MW, Tay ESE, Wang DS, Ong ATL, Wilson C, Phu A, Kok J, Dwyer DE, Bull RA, Lloyd AR, Applegate TL, Dore GJ, Howe AY, Harrigan R, George J

Hepatology communications2020

DOI: 10.1002/hep4.1496 PMID: 32490325

Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.

Lee ER, Parkin N, Jennings C, Brumme CJ, Enns E, Casadellà M, Howison M, Coetzer M, Avila-Rios S, Capina R, Marinier E, Van Domselaar G, Noguera-Julian M, Kirkby D, Knaggs J, Harrigan R, Quiñones-Mateu M, Paredes R, Kantor R, Sandstrom P, Ji H

Scientific reports2020

DOI: 10.1038/s41598-020-58544-z PMID: 32005884

Phylogenetic surveillance of travel-related Zika virus infections through whole-genome sequencing methods.

Kamelian K, Montoya V, Olmstead A, Dong W, Harrigan R, Morshed M, Joy JB

Scientific reports2019

DOI: 10.1038/s41598-019-52613-8 PMID: 31712570

Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEP.

Younger J, Raboud J, Szadkowski L, Harrigan R, Walmsley S, Bayoumi AM, Klein MB, Cooper C, Burchell AN, Loutfy M, Hull M, Wong A, Thomas R, Hogg R, Montaner J, Tsoukas C, Antoniou T, Canadian Observational Cohort Collaboration

Antiviral therapy2019

DOI: 10.3851/imp3302 PMID: 30873953

Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.

Ji H, Enns E, Brumme CJ, Parkin N, Howison M, Lee ER, Capina R, Marinier E, Avila-Rios S, Sandstrom P, Van Domselaar G, Harrigan R, Paredes R, Kantor R, Noguera-Julian M

Journal of the International AIDS Society2018

DOI: 10.1002/jia2.25193 PMID: 30350345

Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control.

Bartha I, McLaren PJ, Brumme C, Harrigan R, Telenti A, Fellay J

PLoS computational biology2017

DOI: 10.1371/journal.pcbi.1005339 PMID: 28182649

Something wrong or missing on this profile? Suggest a correction

Richard Harrigan

Research

Latest papers

Latest funding

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore.

HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade.

Treatment Experience and Repeat Pregnancy Impact the Effectiveness of Non-Nucleoside Reverse Transcription Inhibitor-Highly Active Antiretroviral Therapy for the Prevention of Mother to Child Transmission of Human Immunodeficiency Virus.

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance.

Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.

Phylogenetic surveillance of travel-related Zika virus infections through whole-genome sequencing methods.

Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEP.

Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.

Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control.

Frequent collaborators

Paul Sandstrom

Julio Montaner

Viviane Lima

Robert Hogg

Mark Hull

Mona Loutfy

Evan Wood

Rolando Barrios

Sharon Walmsley

Stanley Read

Bohdan Nosyk

Melanie Murray

Sharon Walmsley

John Kim

Jeffrey Joy

Natalie Prystajecky

Hasina Samji

Réjean Thomas

Kate Shannon

John Gill

Mona Loutfy

Janet Raboud